bosentan
UkraineDrugs containing this active substance
-
The drug is prescribed for the treatment of pulmonary arterial hypertension (PAH) to improve physical endurance and reduce disease symptoms. It is also used to reduce the number of new ulcers on the fingers and toes in adults with systemic sclerosis.
Form: tablets, film-coated
Active substance Dosage bosentan 125 mg ATC: C02KX01
Manufacturer: Accord Healthcare Polska Sp. z o.o. (responsible for batch release)
-
The drug is prescribed for the treatment of pulmonary arterial hypertension (PAH) to improve physical endurance and reduce disease symptoms. It is also used to reduce the number of new ulcers on the fingers and toes in adults with systemic sclerosis.
Form: tablets, film-coated
Active substance Dosage bosentan 62.5 mg ATC: C02KX01
Manufacturer: Pharmascience International Limited (responsible for batch release)
-
The drug is prescribed for the treatment of pulmonary arterial hypertension (PAH) to improve physical endurance and reduce disease symptoms. It is also used to reduce the number of new finger and toe ulcers in adults with systemic sclerosis.
Form: tablets, film-coated
Active substance Dosage bosentan 125 mg ATC: C02KX01
Manufacturer: Pharmascience International Limited (responsible for batch release)
-
The drug is prescribed for the treatment of pulmonary arterial hypertension (PAH) to improve physical endurance and reduce symptoms. It is also used to reduce the number of new digital ulcers on the fingers and toes in adults with systemic sclerosis.
Form: tablets, film-coated
Active substance Dosage bosentan 62.5 mg ATC: C02KX01
Manufacturer: San Pharmaceutical Industries Limited
-
The drug is prescribed for the treatment of pulmonary arterial hypertension (to improve physical endurance and reduce symptoms), as well as to reduce the number of new ulcers on the fingers and toes in patients with systemic sclerosis.
Form: tablets, film-coated
Active substance Dosage bosentan 125 mg ATC: C02KX01
Manufacturer: San Pharmaceutical Industries Limited